Latest Funding Opportunity Guides
Choose Your Area of Innovation:
Or search the full Non-Dilutive Funding Opportunities Database
Advanced Materials & Manufacturing
Aerospace & Spacetech
Agtech & Foodtech
Artificial Intelligence & Machines Learning
Biotech
Cleantech & Climatetech
Cybersecurity
Defensetech & Dual-Use Tech
eXtended Reality
Healthtech
Medtech
Other Tech
Quantum & Photonics
Robotics & Autonomous Systems
ARPA-H SPECTRA ARPA-H-SOL-26-163: Autism Technology and Research Funding Guide for Startups
Deadline: October 18, 2026 (TA4 Solution Summary)
Funding Award Size: Not published (OT awards)
Description: ARPA-H funds wearables, communication devices, and AI tools that improve daily life for autistic people while generating real-world assessment data. See funding fit, technical areas, and how to apply via the ARPA-H Solutions site.
ARPA-H UNIQUE ARPA-H-SOL-26-162: Quantum Entanglement Imaging Program Guide for Startups
Deadline: October 29, 2026 (Solution Summary)
Funding Award Size: Not published (OT awards)
Description: ARPA-H funds teams that turn entangled 511 keV photon pairs into a new kind of medical imaging contrast, paired with quantum-aware AI reconstruction. See funding fit, metrics, and how to apply via the ARPA-H Solutions site.
ARPA-H Emerging Health Innovators (EHI) 2026, ARPA-H-SOL-26-150: Up to $1.05M for Early-Career Researchers
Deadline: October 30, 2026 (Solution Summary)
Funding Award Size: Up to $1.05m
Description: ARPA-H funds early-career researchers at companies, universities, and nonprofits across 16 health topics, from implantable cancer therapy to clinical AI. See funding fit, topics, and how to apply via the ARPA-H Solutions site.
ARPA-H: Systematic Targeting Of MicroPlastics (STOMP)
Deadline: Closed
Funding Award Size: $500k - $10m
Description: Apply to ARPA-H’s STOMP program funding microplastics detection, measurement, and removal technologies. Solution Summary due May 6, 2026 at 5:00PM ET.
ARPA-H SSO: “AGENTIC AI-ENABLED CARDIOVASCULAR CARE TRANSFORMATION” (ADVOCATE)
Deadline: Closed
Funding Award Size: $1 million - $50 million
Description: ARPA-H ADVOCATE funds agentic AI for cardiovascular care, including FDA-regulated clinical AI agents, supervisory AI, and health system deployment.
ARPA-H BioStabilization Systems (BoSS)
Deadline: Closed
Funding Award Size: Likely $10M+
Description: ARPA-H’s BoSS program funds breakthrough technologies that stabilize, manufacture, and distribute live cell-based therapies at ambient temperatures—eliminating the need for ultra-cold storage. Selected teams will build a scalable bioprocessing platform capable of producing thermally stable cells for biologics, gene and cell therapies, regenerative medicine, biosurveillance, blood products, and large-scale genetic testing.
Autonomous Interventions and Robotics (AIR) – ARPA-H-SOL-26-146
Deadline: Closed
Funding Award Size: $2M+
Description: The Autonomous Interventions and Robotics (AIR) program funds development of autonomous robotic surgery technologies in two major areas: (1) fully autonomous endovascular robotic systems for procedures like thrombectomy and embolization, and (2) untethered, autonomous interventional microbots that can diagnose and treat disease with minimally invasive access.
Making Obstetrics Care Smart (MOCS) – ARPA-H
Deadline: Closed
Funding Award Size: $1 Million to $5 Million (Estimate)
Description: ARPA-H’s Making Obstetrics Care Smart (MOCS) program will fund teams to build new placenta diagnostics and noninvasive, wireless, AI-enabled fetal monitoring technologies that can predict fetal oxygen risk and guide safer interventions during labor, with the goal of dramatically reducing maternal and infant morbidity and mortality in the U.S.
ARPA-H Scalable Solutions Office (SSO) BAA
Deadline: Rolling basis until March 5, 2029.
Funding Award Size: Typically varies by project scope; proposers should request only what is necessary to reach a meaningful technical milestone—often $2 million or more for high-impact efforts.
Description: Funding for revolutionary solutions that expand equitable access, affordability, and rapid deployment of health innovations across the U.S. healthcare landscape. The SSO ISO supports scalable technologies that enhance distribution, biomanufacturing, and delivery systems to reach every patient efficiently and affordably.
ARPA-H Resilient Systems Office (RSO) BAA
Deadline: Rolling basis until March 5, 2029.
Funding Award Size: Typically varies by project scope; proposers should request only what is necessary to reach a meaningful technical milestone—often $2 million or more for high-impact efforts.
Description: Funding for transformative health system innovations that strengthen the resilience, adaptability, and interoperability of U.S. healthcare. The RSO ISO supports breakthrough solutions that enhance system robustness, improve efficiency, and safeguard access to care during disruptions.
ARPA-H Proactive Health Office (PHO) BAA
Deadline: Rolling basis until March 5, 2029.
Funding Award Size: Typically varies by project scope; proposers should request only what is necessary to reach a meaningful technical milestone—often $2 million or more for high-impact efforts.
Description: Funding for transformative, prevention-focused innovations that extend health span and avert disease before it occurs. The PHO ISO supports bold solutions in early detection, behavior change, and system-level redesign to build a proactive, resilient, and equitable health future.
ARPA-H Health Science Futures (HSF) Mission Office BAA
Deadline: Rolling basis until March 5, 2029.
Funding Award Size: Typically varies by project scope; proposers should request only what is necessary to reach a meaningful technical milestone—often $2 million or more for high-impact efforts.
Description: Funding for revolutionary, disease-agnostic health innovations that remove scientific and technological barriers to next-generation healthcare. The HSF ISO supports cutting-edge tools, technologies, and platforms with the potential for real-world translational impact.